| • |
Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation
van der Meer RW, Rijzewijk LJ, de Jong HW, et al
Circulation. 2009;119(15):2069-2077 |
| • |
New drugs for the treatment of diabetes mellitus: part I: Thiazolidinediones and their evolving cardiovascular implications.
McGuire DK, Inzucchi SE.
Circulation. 2008 Jan 22;117(3):440-9. |
| • |
Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.
Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P; American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.
Circulation. 117(12):1610-9 |
| • |
General cardiovascular risk profile for use in primary care: the Framingham Heart Study.
D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB.
Circulation. 117(6):743-53 |
| • |
Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.
Chan PS, Nallamothu BK, Gurm HS, Hayward RA, Vijan S.
Circulation. 2007 May 8;115(18):2398-409 |
| • |
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association
Buse JB, Ginsberg HN, Bakris GL, et al
Circulation. 2007;115:114-126 |
| • |
Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study
Fox CS, Pencina MJ, Meigs JB, et al
Circulation. 2006;113:2914-2918 |
| • |
Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee
Lichtenstein AH, Appel LJ, Brands M, et al for the AHA Nutrition Committee
Circulation. 2006;114:82-96 |
| • |
Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study
Dekker JM, Girman C, Rhodes T, et al
Circulation. 2005;112:666-673 |
| • |
Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study
Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM
Circulation. 2005;111:583-590 |
| • |
Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome
Salmenniemi U, Ruotsalainen E, Pihlajamaki J, et al
Circulation. 2004;110:3842-3848 |
| • |
Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey
de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N
Circulation. 2004;110:2494-2497 |
| • |
Left Ventricular Remodeling and Heart Failure in Diabetic Patients Treated With Primary Angioplasty for Acute Myocardial Infarction
Carrabba N, Valenti R, Parodi G, Santoro GM, Antoniucci D
Circulation. 2004;110:1974-1979. Epub 2004 Sep 27 |
| • |
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy
de Zeeuw D, Remuzzi G, Parving HH, et al.
Circulation. 110:921-927 |
| • |
Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults
Malik S, Wong ND, Franklin SS
Circulation. 2004;110:1239-1244 |
| • |
Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus
Esposito K, Giugliano D, Nappo F, Marfella R
Circulation. 2004;110:214-219 |
| • |
Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?
Ridker PM, Wilson PW, Grundy SM
Circulation. 2004;109:2818-2825 |
| • |
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease. A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
Sarnak MJ, MD, Cochair, Levey AS, MD, Cochair, Schoolwerth AC, MD, Cochair, et al
Circulation. 2003;108:2154-2169 |
| • |
Association of Insulin Resistance, Hyperleptinemia, and Impaired Nitric Oxide Release With In-Stent Restenosis in Patients Undergoing Coronary Stenting
Piatti PM, Di Mario C, Monti LD, et al
Circulation. 2003;108:2074-2081 |
| • |
Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells
Calabró P, Willerson JT, Yeh ETH, et al
Circulation. 2003;108:1930-1932 |
| • |
Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study
Sattar N, Gaw A, Scherbakova O, et al
Circulation. 2003;108:414-419 |
| • |
Arterial Stiffness Increases With Deteriorating Glucose Tolerance Status: The Hoorn Study
Henry RMA, Kostense PJ, Spijkerman AMW, et al
Circulation. 2003;107:2089-2095 |
| • |
Physical Activity in Relation to Cardiovascular Disease and Total Mortality Among Men With Type 2 Diabetes
Tanasescu M, Leitzmann MF, Rimm EB, Hu FB
Circulation. 2003;107:2435-2439 |
| • |
Prospective Study of Sudden Cardiac Death Among Women in the United States
Albert CM, Chae CU, Grodstein F, et al
Circulation. 2003;107:2096-2101 |
| • |
Relationships Between Low-Density Lipoprotein Particle Size, Plasma Lipoproteins, and Progression of Coronary Artery Disease. The Diabetes Atherosclerosis Intervention Study (DAIS)
Vakkilainen J, Steiner G, Ansquer J-C, et al.
Circulation. 2003;107:1733-1737 |
| • |
Intensive Blood Pressure Control Reduces the Risk of Cardiovascular Events in Patients With Peripheral Arterial Disease and Type 2 Diabetes
Mehler PS, Coll JR, Estacio R, Esler A, Schrier RW, Hiatt WR
Circulation. 2003;107:753-756. |
| • |
Vascular Structural and Functional Changes in Type 2 Diabetes Mellitus
Schofield I, Malik R, Izzard A, Austin C, Heagerty A
Circulation. 2002;106:3037-3043 |
| • |
Pioglitazone May Find a Role in Reducing Restenosis After Arterial Interventions
|
| • |
In Persons Without Diabetes, Acute Hyperglycemia Impairs Endothelial Function, Perhaps Through the Production of Oxygen-Derived Free Radicals, and This Is Reversed With Vitamin C
|
| • |
Treating Hyperlipidemia in Diabetic Adults Is Predicted to Be Effective and Cost-effective in the Primary and Secondary Prevention of Cardiovascular Events
|
| • |
Treating Hyperlipidemia in Diabetic Adults Is Predicted to Be Effective and Cost-effective in the Primary and Secondary Prevention of Cardiovascular Events
Freeman DJ, Norrie J, Sattar N, et al.
Circulation. 2001;103:357-362 |
| • |
Diabetes Raises the Risk of Thrombosis in Atheromatous Coronary Arteries
|
| • |
Left Ventricular Hypertrophy Is Not Influenced Directly by Insulin Level, Secretion Rate, or Sensitivity
|
| • |
Treating Hyperlipidemia in Diabetic Adults Is Predicted to Be Effective and Cost-effective in the Primary and Secondary Prevention of Cardiovascular Events
|
| • |
A Simple Method of Screening Men for Increased CAD Risk
|
| • |
Obesity: A Risk Factor for CVD in Men
Steinberg HO, Paradisi G, Cronin J, et al.
Circulation. 2000;101:2040-2046 |
| • |
Diabetes Adversely Affects Left Ventricular Function
Devereux RB, Roman MJ, Paranicas M, et al.
Circulation. 2000;101:2271-2276 |
| • |
Insulin Resistance: an Independent Risk Factor for Endothelial Dysfunction
Balletshofer B, Rittig K, Enderle MD, et al.
Circulation. 2000;101:1780-1784 |
| • |
Aspirin Use Not So Common in Patients With Coronary Artery Disease
Stafford RS.
Circulation. 2000;101:1097-1101 |
| • |
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association
Buse JB, Ginsberg HN, Bakris GL, et al
Circulation. 2007;115:114-126 |
| • |
Coronary Revascularization in Diabetic Patients: A Comparison of the Randomized and Observational Components of the Bypass Angioplasty Revascularization Investigation (BARI)
|
